Knokke-Heist (Belgium), 27 January 2026, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON), a leading innovator in oral and dental care, today provides an update on the year 2025 which has been a decisive period, marked by regulatory achievements, sustained innovation and accelerating commercial momentum. In an environment shaped by increasingly stringent European regulations and rising international standards, bonyf has reinforced its position as a compliant, innovation-driven medical device group.
Author: bonyf
Company Update on Market Trading Dynamics and Business Fundamentals
Knokke-Heist (Belgium), 22 December 2025, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON), a leading innovator in oral and dental care, today provides a clarification regarding recent share price movements and trading liquidity, emphasizing that these market dynamics do not reflect the Company’s underlying operational performance or financial health.
PerioCream becomes the most in-demand bonyf innovation
Knokke-Heist (Belgium), 24 November 2025, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON), a leader in dental consumer goods, professional dental consumables and dermatological solutions, announces a faster and successful roll out of its newest dental care innovation namely, PerioCream Periodontal Paste, a mucoadhesive formulation based on NitrAdine®, applied by dental professionals as an adjunct to Scaling and Root Planing (SRP).
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
Knokke-Heist (Belgium), 15 October 2025, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON) announces today that its brand, PerioCream, a mucoadhesive formulation based on NitrAdine®, applied by dental professionals as an adjunct to Scaling & Root Planing (SRP) has been granted a certification as a Class IIa medical device according to Medical Device Regulation (EU) 2017/745 Annex IX Chapter I+III.
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf
Knokke-Heist (Belgium), 15 September 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) announces its participation at ExpoPharm 2025, one of Europe’s largest pharmaceutical trade fairs, held in Düsseldorf from 16 to 18 September 2025.
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments
Knokke-Heist (Belgium), 5 September 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) announces that the capital increase previously under consideration has been cancelled, following a series of significant and positive business developments.
Periocream: The Future Commercial Winner for bonyf
Knokke-Heist (Belgium), 11 August 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) is preparing to launch Periocream, a groundbreaking dental treatment designed exclusively for dental professionals. At bonyf, we expect our Notified Body to release the final report shortly, confirming the product’s readiness for market.
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
Knokke-Heist (Belgium), 14 July 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) addresses the recent pressure on its share price and reaffirms its strong fundamentals, expanding global footprint, and ambitious roadmap for sustained growth.
Annual Results 2024
Knokke-Heist (Belgium), 30 June 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents its 2024 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.
bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India
Knokke-Heist (Belgium), 3 June 2025, 6:00 p.m.; bonyf NV (Ticker: MLBON) is proud to announce that Group Pharmaceuticals, a leading Indian oral health company, has become a significant stakeholder in bonyf NV.









